Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunlin Zhuang

Showing results (61-70 of 141) with videos related to

Pageof 15
Sort By:
European Journal of Medicinal Chemistry|July 27, 2020
Bioisosterism-based design and enantiomeric profiling of chiral hydroxyl-substituted biphenyl-diarylpyrimidine nonnucleoside HIV-1 reverse transcriptase inhibitorsXiaomei Chen, Li Ding, Yuan Tao, et al.
Bioorganic & Medicinal Chemistry Letters|May 8, 2021
Enantiomeric profiling of a chiral benzothiazole necroptosis inhibitorJing Zhu, Zhuo Qu, Jiaxuan Huang, et al.
Journal of Medicinal Chemistry|April 30, 2025
Bardoxolone Derivatives as Novel Pseudo-Natural Necroptosis Inhibitors by Destabilizing HSP90 Client ProteinsYu Zou, Yue Chai, Bolin Du, et al.
Journal of Medicinal Chemistry|March 13, 2023
Targeting Receptor-Interacting Protein Kinase 1 by Novel Benzothiazole Derivatives: Treatment of Acute Lung Injury through the Necroptosis PathwayXinqi Zhang, Qianyu Han, Ruilin Hou, et al.
ACS Pharmacology & Translational Science|May 16, 2024
Structure-Activity Relationship Study of (<i>E</i>)-3-(6-Fluoro-1<i>H</i>-indol-3-Yl)-2-methyl-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one (FC116) Against Metastatic Colorectal Cancers Resistant to OxaliplatinShuyu Wang, Qinghua Ge, Hui Cong, et al.
Journal of Medicinal Chemistry|May 31, 2023
Fragment-Based Discovery of Azocyclic Alkyl Naphthalenesulfonamides as Keap1-Nrf2 Inhibitors for Acute Lung Injury TreatmentJianyu Yan, Yue Li, Li Ding, et al.
Molecular Diversity|February 18, 2026
Discovery of 5-fluoro-aminopyrimidine derivatives as dual BTK/FLT3 inhibitors for the treatment of rheumatoid arthritisFansheng Ran, Yifan Ma, Tiantian Sun, et al.
Journal of Medicinal Chemistry|June 10, 2022
Crystallography-Guided Optimizations of the Keap1-Nrf2 Inhibitors on the Solvent Exposed Region: From Symmetric to Asymmetric NaphthalenesulfonamidesGuodong Liu, Ruilin Hou, Lijuan Xu, et al.
Molecules (Basel, Switzerland)|March 1, 2020
Design of Biphenyl-Substituted Diarylpyrimidines with a Cyanomethyl Linker as HIV-1 NNRTIs via a Molecular Hybridization StrategyYuan Lei, Sheng Han, Yang Yang, et al.
Journal of Medicinal Chemistry|January 25, 2019
Inhibitor of Apoptosis Protein (IAP) Antagonists in Anticancer Agent Discovery: Current Status and PerspectivesHui Cong, Lijuan Xu, Yougen Wu, et al.
Pageof 15

Showing results (61-70 of 141) with videos related to

Sort By:
Pageof 15
European Journal of Medicinal Chemistry|July 27, 2020
Bioisosterism-based design and enantiomeric profiling of chiral hydroxyl-substituted biphenyl-diarylpyrimidine nonnucleoside HIV-1 reverse transcriptase inhibitorsXiaomei Chen, Li Ding, Yuan Tao, et al.
Bioorganic & Medicinal Chemistry Letters|May 8, 2021
Enantiomeric profiling of a chiral benzothiazole necroptosis inhibitorJing Zhu, Zhuo Qu, Jiaxuan Huang, et al.
Journal of Medicinal Chemistry|April 30, 2025
Bardoxolone Derivatives as Novel Pseudo-Natural Necroptosis Inhibitors by Destabilizing HSP90 Client ProteinsYu Zou, Yue Chai, Bolin Du, et al.
Journal of Medicinal Chemistry|March 13, 2023
Targeting Receptor-Interacting Protein Kinase 1 by Novel Benzothiazole Derivatives: Treatment of Acute Lung Injury through the Necroptosis PathwayXinqi Zhang, Qianyu Han, Ruilin Hou, et al.
ACS Pharmacology & Translational Science|May 16, 2024
Structure-Activity Relationship Study of (<i>E</i>)-3-(6-Fluoro-1<i>H</i>-indol-3-Yl)-2-methyl-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one (FC116) Against Metastatic Colorectal Cancers Resistant to OxaliplatinShuyu Wang, Qinghua Ge, Hui Cong, et al.
Journal of Medicinal Chemistry|May 31, 2023
Fragment-Based Discovery of Azocyclic Alkyl Naphthalenesulfonamides as Keap1-Nrf2 Inhibitors for Acute Lung Injury TreatmentJianyu Yan, Yue Li, Li Ding, et al.
Molecular Diversity|February 18, 2026
Discovery of 5-fluoro-aminopyrimidine derivatives as dual BTK/FLT3 inhibitors for the treatment of rheumatoid arthritisFansheng Ran, Yifan Ma, Tiantian Sun, et al.
Journal of Medicinal Chemistry|June 10, 2022
Crystallography-Guided Optimizations of the Keap1-Nrf2 Inhibitors on the Solvent Exposed Region: From Symmetric to Asymmetric NaphthalenesulfonamidesGuodong Liu, Ruilin Hou, Lijuan Xu, et al.
Molecules (Basel, Switzerland)|March 1, 2020
Design of Biphenyl-Substituted Diarylpyrimidines with a Cyanomethyl Linker as HIV-1 NNRTIs via a Molecular Hybridization StrategyYuan Lei, Sheng Han, Yang Yang, et al.
Journal of Medicinal Chemistry|January 25, 2019
Inhibitor of Apoptosis Protein (IAP) Antagonists in Anticancer Agent Discovery: Current Status and PerspectivesHui Cong, Lijuan Xu, Yougen Wu, et al.
Pageof 15